Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
16,427,090
-
Share change
-
-435,023
-
Total reported value
-
$365,743,034
-
Put/Call ratio
-
126%
-
Price per share
-
$22.26
-
Number of holders
-
111
-
Value change
-
-$11,898,095
-
Number of buys
-
55
-
Number of sells
-
60
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q4 2015
As of 31 Dec 2015,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,427,090 shares.
The largest 10 holders included
FMR LLC, Aisling Capital LLC, Pentwater Capital Management LP, STATE STREET CORP, COLUMBUS CIRCLE INVESTORS, BB BIOTECH AG, VANGUARD GROUP INC, WASATCH ADVISORS INC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, and BlackRock Fund Advisors.
This page lists
111
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.